Recent outbreaks, like the deadly Bundibugyo ebolavirus, are a reminder of how quickly dangerous pathogens can emerge and spread, but they also hint at what is possible when the right capabilities, pa...

YouTube video by CEPI

The Board of Cepi, the Confederation of European Paper Industries, has appointed Francesca Stevens as its next Director General. An experienced European industry advocate, she takes up the position on...

콩고민주공화국의 분디부교 에볼라 현장에서 WHO 아프리카 지역사무소와 CEPI, 콩고 국립생의학연구소가 클로드를 쓰고 있어요. 하루 걸리던 상황보고서가 1시간 안쪽으로 줄었는데, 백신이 없는 병과의 싸움에서 그 시간은 무엇을 바꿀까요?

Anthropic's Claude is being used by CEPI, WHO AFRO and INRB Kinshasa to support the response to a Bundibugyo virus Ebola outbreak in the Democratic Republic of the Congo. The deployment is notable not as a consumer AI release, but as a live, multi-institution public-health workflow spanning field reporting, evidence monitoring, epidemiological modeling and genomic analysis. According to Anthropic's account of the Ebola response collaboration, the work involves its Beneficial Deployments and Applied AI teams alongside the health partners. Claude is intended to help specialists move information from collection and analysis to decision-relevant briefings more quickly. Human public-health experts remain responsible for interpreting outputs and making response decisions. The operational setting matters. Bundibugyo virus, or BDBV, is one of the viruses that can cause Ebola virus disease, and Anthropic says no approved vaccine exists for BDBV. CEPI and its partners are pursuing work that includes vaccine development, cross-protection research and related studies, while outbreak operations also depend on surveillance, infection prevention and control, case management, diagnostics and coordinated situation reporting. ## How Claude is being used in the outbreak response A central application is the situation report, often called a sitrep. These reports consolidate updates from field teams and other response participants so that decision-makers can understand the current picture. Anthropic says Claude helps analyze community health worker data and streamline sitrep production, reducing the turnaround from a full-day process to **under an hour**. That faster cycle does not mean an AI system is replacing epidemiologists, laboratory teams or incident managers. Rather, it can reduce the time spent organizing and synthesizing a large volume of incoming information, giving expert teams more time to assess findings, reconcile uncertainty and decide what action is appropriate. Anthropic also describes Claude supporting several connected activities: * **Field-data analysis and sitrep preparation** from community health workers. * **Research evidence organization and monitoring** as knowledge relevant to the outbreak develops. * **Disease modeling and forecasting** , including support for multiple concurrent modeling efforts. * **Bioinformatics workflows** through Claude Science, including genome assembly and phylogenetic analysis. Together, these uses show where AI can fit in an outbreak-response operation: not as a single prediction engine, but as assistance across the data-to-decision process. Field information, research literature, model outputs and laboratory data each have different formats and reliability constraints. The value of an AI-assisted workflow depends on whether those inputs can be handled quickly without losing the context experts need to judge them. Workflow area | Previous or manual process described | Claude-supported approach described by Anthropic ---|---|--- Situation reports | A full-day turnaround | Analysis of field data and streamlined sitrep production in under an hour Research evidence | Evidence must be organized and monitored across the response | Claude supports evidence organization and monitoring Modeling | Response teams need to assess outbreak dynamics | Claude supports disease modeling, forecasting and concurrent modeling efforts Genomic analysis | Laboratory data require specialist bioinformatics work | Claude Science workflows support genome assembly and phylogenetic analysis ### Why the deployment matters beyond one outbreak The strongest implication is speed with expert review, rather than automation for its own sake. In a fast-moving response, a report that arrives late may be less useful even when its underlying information is sound. Compressing the administrative and analytical path from field data to a reviewable briefing can help teams coordinate around a more current operational picture. The deployment also combines types of work that are too often discussed separately. Natural-language systems can help turn unstructured updates and research material into usable summaries. At the same time, scientific workflows can assist with technical tasks such as genome assembly and phylogenetic analysis. Bringing these capabilities into one response environment raises the prospect of better handoffs between field operations, disease modeling and laboratory investigation. For organizations building AI-enabled health tools, the case illustrates an important design principle: useful systems must serve established expert workflows. A practical tool needs clearly defined inputs, traceable review steps and outputs that teams can use within existing reporting and scientific processes. A general-purpose model alone is not the workflow. There are equally important limits. Anthropic's description presents Claude as decision support, not an autonomous public-health authority. AI-generated summaries, analyses or proposed interpretations need expert scrutiny, particularly where incomplete reports, changing case definitions or conflicting evidence could affect conclusions. The long-term impact of this deployment will require independent evaluation and transparent documentation of safety, performance and real-world outcomes. For businesses working with sensitive operational data, the lesson is direct: AI creates the most value when it shortens a bottleneck while preserving accountable human review. Scalevise helps teams identify where AI can reduce manual synthesis, connect information flows and fit into day-to-day processes without treating a model output as a final decision. Explore Scalevise's AI automation services to discuss an AI automation project. ## Frequently Asked Questions **What is Claude doing in the DRC Ebola outbreak response?** Anthropic says Claude supports field-data analysis, situation-report production, research evidence monitoring, disease modeling and forecasting, plus bioinformatics tasks such as genome assembly and phylogenetic analysis. **Which organizations are involved in the Claude deployment?** The collaboration involves Anthropic, CEPI, WHO AFRO and INRB Kinshasa in support of the Bundibugyo virus Ebola outbreak response in the Democratic Republic of the Congo. **How much faster are situation reports with Claude?** Anthropic says the Claude-supported workflow reduces sitrep turnaround from a full-day process to under an hour. **Does Claude make public-health decisions in this response?** No. Claude is used as decision support. Human public-health experts interpret its outputs and remain responsible for response decisions. **Why is genomic analysis part of an AI-assisted outbreak workflow?** Genomic work can help teams analyze virus sequences and relationships. Anthropic says Claude Science workflows support genome assembly and phylogenetic analysis within the response. ### Conclusion Claude's use in the DRC Bundibugyo Ebola response is a concrete example of AI being applied across public-health information workflows rather than as a standalone tool. Its reported value lies in helping expert teams process field, research, modeling and genomic information faster. The deployment's broader significance will depend on continued human oversight, transparent evaluation and whether the faster workflows produce reliable operational benefits.

Norge vil bidra med til sammen 1 milliard kroner til det internasjonale vaksine- og beredskapssamarbeidet CEPI sin neste strategiperiode. Målet er å styrke verdens evne til å oppdage og stanse framtidige epidemier og pandemier gjennom forskning, innovasjon og utvikling av nye vaksiner, melder regjeringen.